Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data XCel Brands, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
32.7
31.7
35.5
41.7
29.4
37.9
25.8
17.8
8.26
4.94
Cost of revenue
0.2
2.7
10.3
5.46
10.7
7.98
6.92
0.45
Gross profit
32.6
31.7
32.8
31.5
24
27.3
17.8
10.8
7.81
4.94
Selling, general and administrative
5.69
4.7
5.21
5.55
9.74
14.4
16.3
13.3
6.84
4.65
Operating expenses
0.62
Operating income
4.87
-9.22
3.93
-2.61
-16.4
-12.6
-2.26
-20.6
-21.4
-13.2
Interest expense
1.33
1.17
0.91
1.29
1.19
1.92
1.19
0.11
0.62
2.08
Pre-tax income
3.02
-10.6
2.92
-4.09
-17.6
-16.1
-5.79
-21
-22.3
-17.5
Income tax
0.32
-0.45
1.83
-0.64
-4.52
-3.11
-0.43
1.21
0.22
0.08
Income from continuing operations
2.7
-10.1
Net income to minority interests
-0.02
-0.15
-0.85
-1.34
-1.19
-0.17
-0.11
Net income
2.74
-10.1
1.09
-3.43
-12.9
-12.2
-4.02
-21.1
-22.4
-17.5
EBITDA
6.43
-7.66
5.71
1.29
-10.9
-5.73
5
-13.7
-16.5
-9.64
EPS, basic
-5.49
0.60
-1.80
-6.79
-6.29
-2.00
-10.68
-9.84
-5.08
EPS, diluted
-5.49
0.60
-1.80
-6.79
-6.29
-2.00
-10.68
-9.84
-5.08
Shares, basic (weighted)
18.6
1.85
1.83
1.89
1.92
1.95
1.97
1.97
2.28
3.44
Shares, diluted (weighted)
19
1.85
1.83
1.89
1.92
1.95
1.97
1.97
2.28
3.44
Balance sheet
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
14.1
10.2
8.84
4.64
4.96
4.48
4.61
3
1.25
1.15
Receivables
6.97
8.53
11
10.6
8.89
7.64
5.11
3.45
2.27
0.96
Inventory
0
1.99
0.9
1.22
3.38
2.85
0.45
0
Other current assets
0.81
0.59
2.04
1.4
1.09
1.68
1.46
0.4
0.52
1.56
Total current assets
21.9
19.3
23.9
17.6
16.1
17.2
14
7.3
4.04
3.67
Property, plant and equipment
2.6
2.38
3.2
3.67
3.37
2.55
1.42
0.63
0.18
0.13
Lease right-of-use assets
0
9.25
8.67
6.31
5.42
4.45
3.75
3.01
Goodwill
12.4
0
Intangible assets
111
110
109
111
93.5
98.3
47.7
41.5
34.8
31.2
Other non-current assets
1.52
1.71
0.51
0.51
0.23
0.56
0.11
0.02
0.91
0.91
Total assets
151
135
138
143
123
126
88.9
71.7
53.8
38.9
Accounts payable
1.52
1.26
5.14
4.39
4.44
6.17
3.87
2.24
2.73
0.62
Accrued liabilities
2.19
2.27
2.01
1.44
0.97
0.58
0.42
0.11
Deferred revenue
0.02
0.27
0.09
0.89
1.38
1.33
Short-term debt
6.43
5.46
5.33
2.25
2.8
2.5
0.75
3.25
Total current liabilities
10.4
9.11
16.1
9.84
10.3
10.5
6.56
6.47
10.4
7.49
Long-term debt
25.5
19.4
11.3
16.6
13.8
25.5
3.97
6.57
9.46
Lease liabilities
0
9.77
8.47
7.25
5.84
4.02
5.3
3.68
Other non-current liabilities
0.42
0.22
0.22
0.04
0.43
0.72
Total liabilities
44.9
37.3
38.2
44.7
36.8
50.8
18.8
23.5
25.4
23.1
Total debt
31.9
24.9
19.6
18.8
16.6
28
4.72
6.57
12.7
Paid-in capital
97.4
99
100
102
102
103
104
104
107
112
Retained earnings
8.8
-1.32
-0.23
-3.66
-16.6
-28.8
-32.8
-53.8
-76.2
-93.7
Shareholders' equity
106
97.7
99.9
98.1
85.7
74.3
70.8
50
30.4
18
Minority interests
0.36
0.51
0.66
-0.68
-1.86
-2.03
-2.14
Total equity
106
97.7
99.9
98.5
86.3
74.9
70.1
48.2
28.4
15.8
Total liabilities and equity
151
135
138
143
123
126
88.9
71.7
53.8
38.9
Shares outstanding
18.6
1.84
1.82
1.89
1.93
1.96
1.97
1.98
2.37
5.88
Cash flow statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
2.74
-10.1
1.09
-3.45
-13.1
-13
-5.36
-22.2
-22.6
-17.6
Depreciation and amortization
1.56
1.56
1.78
3.9
5.5
6.83
7.26
6.95
4.95
3.59
Stock-based compensation
4.73
3.18
1.79
0.98
0.85
0.72
0.62
0.24
0.4
0.57
Deferred income tax
0.17
-0.53
1.76
-0.71
-4.38
-3.19
-0.97
1.11
Change in receivables
0.63
-1.57
-2.65
0.44
0.69
1.15
2.12
1.58
1.17
1.28
Change in inventory
0
-1.99
1.09
-0.32
-2.16
0.53
2.39
0.45
Cash from operations
7.92
4.68
6.59
3.5
3.19
-6.56
-14.2
-6.55
-4.72
-7.02
Capital expenditures
-2.16
-0.21
-1.48
-1.13
-0.75
-1.1
-0.27
-0.1
-0.11
-0.01
Cash from investing
-2.76
-0.24
-1.48
-10.3
-0.7
-4.8
44.5
0.21
-0.11
-0.01
Debt issued
7.5
54
5
7.95
5.67
Debt repaid
-5.5
-7.18
-5.46
-4.74
-2.25
-41.8
-29
-5
-0.75
Stock issued
0.02
0
0.01
0.03
Share buybacks
-1.43
-1.2
-1.03
-0.17
-0.19
-0.02
-0.44
-0.11
-0.2
Cash from financing
-7.49
-8.38
-6.49
2.27
-2.17
10.5
-31
4.73
3.82
7.93
Net change in cash
-2.33
-3.94
-1.38
-4.57
0.32
-0.84
-0.61
-1.61
-1.01
0.9
Free cash flow
5.76
4.47
5.12
2.37
2.44
-7.65
-14.4
-6.65
-4.83
-7.03
Interest paid
1.26
1.25
0.97
1.18
1.13
1.8
1.03
0.06
0.51
0.81
Income taxes paid
0.23
0.17
0.3
0.14
0.06
0.09
0.1
0.52
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $0.79 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Operating margin
-282.6%
Operating income / revenue.
EBITDA margin
-205.6%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-344.8%
Pre-tax income / revenue.
Net margin
-343.7%
Net income / revenue.
Operating cash flow margin
-130.9%
Cash from operations / revenue.
Return on equity (ROE)
-112.9%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-48.2%
Net income / average total assets.
Return on invested capital (ROIC)
-39.8%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue
104.5%
Selling, general and administrative expense / revenue.
Stock-based pay / revenue
14.2%
Stock-based compensation (from the cash flow statement) / revenue.
D&A / revenue
76.9%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
-40.2%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
-42.4%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
-30.0%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y
-36.8%
Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y
-34.8%
Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y
-27.1%
Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y
-41.0%
Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y
-36.7%
Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y
-26.8%
Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y
-27.6%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-24.1%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
-20.6%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
51.0%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
20.4%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
12.4%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
0.28x
Current assets / current liabilities.
Quick ratio
0.18x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.07x
(Cash + short-term investments) / current liabilities.
Debt / equity
0.87x
Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets
37.2%
Total debt / total assets.
Liabilities / assets
63.9%
Total liabilities / total assets.
Net debt
$11.7M
Total debt - cash - short-term investments. Negative means more cash than debt.
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$0.74
Revenue / diluted weighted shares.
Operating cash flow per share
-$0.97
Cash from operations / diluted weighted shares.
Book value per share
$2.14
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
1.14x
Market cap / revenue.
P/B
0.37x
Market cap / shareholders' equity. Only when equity is positive.
EV/Sales
3.71x
Enterprise value / revenue.
Earnings yield
-301.8%
Net income / market cap (the inverse of P/E).
Shareholder yield
3.7%
(Dividends paid + share buybacks) / market cap.
What was XCel Brands, Inc.'s revenue in fiscal 2025?
XCel Brands, Inc. reported revenue of $4.9M for fiscal 2025, 40.2% lower than the year before.
Was XCel Brands, Inc. profitable in fiscal 2025?
No. It reported a net loss of $17.5M.
How much free cash flow did XCel Brands, Inc. generate in fiscal 2025?
Cash from operations of $7.0M minus capital expenditures of $10.0K left free cash flow of -$7.0M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.